נורווגיה -
נורבגית -
Statens legemiddelverk
thallous (201ti) chloride 37 mbq/ ml
curium netherlands b.v. - talliumklorid (201tl) - injeksjonsvæske, oppløsning - 37 mbq/ ml
האיחוד האירופי -
נורבגית -
EMA (European Medicines Agency)
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiske midler - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
נורווגיה -
נורבגית -
Statens legemiddelverk
lidocaine accord 10 mg/ ml
accord healthcare b.v. - lidokainhydroklorid - injeksjonsvæske, oppløsning - 10 mg/ ml
נורווגיה -
נורבגית -
Statens legemiddelverk
lidocaine accord 20 mg/ ml
accord healthcare b.v. - lidokainhydroklorid - injeksjonsvæske, oppløsning - 20 mg/ ml
נורווגיה -
נורבגית -
Statens legemiddelverk
adenuric 80 mg
2care4 aps - febuksostat - tablett, filmdrasjert - 80 mg
האיחוד האירופי -
נורבגית -
EMA (European Medicines Agency)
vyvgart
argenx - efgartigimod alfa - myasthenia gravis - immunsuppressive - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.
נורווגיה -
נורבגית -
Statens legemiddelverk
lidokain mylan 10 mg/ ml
mylan ireland limited - lidokainhydrokloridmonohydrat - injeksjonsvæske, oppløsning - 10 mg/ ml
נורווגיה -
נורבגית -
Statens legemiddelverk
lidokain mylan 20 mg/ ml
mylan ireland limited - lidokainhydrokloridmonohydrat - injeksjonsvæske, oppløsning - 20 mg/ ml
נורווגיה -
נורבגית -
Statens legemiddelverk
rapydan 70 mg / 70 mg
eurocept international b.v - lidokain / tetrakain - medisinert plaster - 70 mg / 70 mg